Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

16.7%

22 terminated/withdrawn out of 132 trials

Success Rate

82.7%

-3.9% vs industry average

Late-Stage Pipeline

53%

70 trials in Phase 3/4

Results Transparency

58%

61 of 105 completed trials have results

Key Signals

1 recruiting61 with results20 terminated

Enrollment Performance

Analytics

Phase 3

46(40.4%)

Phase 2

29(25.4%)

Phase 4

24(21.1%)

Phase 1

11(9.6%)

N/A

4(3.5%)

114Total

Phase 3(46)

Phase 2(29)

Phase 4(24)

Phase 1(11)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (132)

Showing 20 of 132 trials

NCT05026216Phase 4Completed

To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.

Role: collaborator

NCT05152173Phase 2Completed

Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis

Role: lead

NCT06169319Phase 2Completed

A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)

Role: lead

NCT05254457Phase 3Completed

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

Role: lead

NCT04456296Phase 4Completed

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Role: lead

NCT05419505Phase 2Completed

Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks

Role: lead

NCT04786106Phase 4Active Not Recruiting

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

Role: collaborator

NCT06649539Phase 4Recruiting

Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease

Role: collaborator

NCT05877066Terminated

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Role: lead

NCT05873595Terminated

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease

Role: lead

NCT03518034Phase 4Completed

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Role: collaborator

NCT01013025Completed

Vantas Implant Retrieval Study

Role: lead

NCT00644033Phase 3Completed

A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

Role: lead

NCT00904540Phase 4Completed

Topical Lidocaine Patch in Low Back Pain

Role: lead

NCT01035983Phase 3Completed

Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches

Role: lead

NCT00225797Phase 3Completed

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

Role: lead

NCT00226421Phase 3Completed

Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

Role: lead

NCT00475514Phase 3Completed

A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine

Role: lead

NCT00904020Phase 4Completed

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Role: lead

NCT04381117Completed

Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

Role: lead